ZYME: Zymeworks Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Zymeworks Inc (ZYME).
$1.01B Market Cap.
ZYME Market Cap. (MRY)
ZYME Shares Outstanding (MRY)
ZYME Assets (MRY)
Total Assets
$463.09M
Total Liabilities
$124.32M
Total Investments
$258.10M
ZYME Income (MRY)
Revenue
$76.30M
Net Income
-$122.69M
Operating Expense
$213.41M
ZYME Cash Flow (MRY)
CF Operations
-$110.04M
CF Investing
$38.76M
CF Financing
-$20.45M
ZYME Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $463,091,000 (-20.28%) | $580,880,000 (-10.46%) | $648,725,000 (66.71%) | $389,132,000 (-27.72%) |
Assets Current | $300,451,000 (-27.24%) | $412,926,000 (-24.19%) | $544,706,000 (88.99%) | $288,220,000 (-36.67%) |
Assets Non-Current | $162,640,000 (-3.16%) | $167,954,000 (61.46%) | $104,019,000 (3.08%) | $100,912,000 (21.14%) |
Goodwill & Intangible Assets | $16,592,000 (-15.66%) | $19,672,000 (-5.29%) | $20,771,000 (31.01%) | $15,854,000 (-8.46%) |
Shareholders Equity | $338,768,000 (-27.12%) | $464,806,000 (-5.71%) | $492,956,000 (97.90%) | $249,094,000 (-39.23%) |
Property Plant & Equipment Net | $34,316,000 (-8.60%) | $37,543,000 (-21.21%) | $47,650,000 (-4.26%) | $49,770,000 (182.56%) |
Cash & Equivalents | $66,103,000 (-58.05%) | $157,557,000 (-60.70%) | $400,912,000 (98.60%) | $201,867,000 (-16.60%) |
Accumulated Other Comprehensive Income | -$6,952,000 (-5.29%) | -$6,603,000 (0.84%) | -$6,659,000 (0.00%) | -$6,659,000 (0.00%) |
Deferred Revenue | $40,195,000 (9.70%) | $36,640,000 (11.23%) | $32,941,000 (0.00%) | $32,941,000 (0.00%) |
Total Investments | $258,101,000 (-13.59%) | $298,700,000 (223.95%) | $92,206,000 (78.60%) | $51,627,000 (-75.44%) |
Investments Current | $159,673,000 (-26.34%) | $216,770,000 (137.37%) | $91,320,000 (79.97%) | $50,741,000 (-72.47%) |
Investments Non-Current | $98,428,000 (20.14%) | $81,930,000 (9147.18%) | $886,000 (0.00%) | $886,000 (-96.58%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $55,815,000 (186.57%) | $19,477,000 (-41.69%) | $33,400,000 (113.91%) | $15,614,000 (2.10%) |
Trade & Non-Trade Payables | $59,838,000 (30.11%) | $45,992,000 (-47.42%) | $87,468,000 (39.30%) | $62,789,000 (43.83%) |
Accumulated Retained Earnings (Deficit) | -$830,335,000 (-22.57%) | -$677,437,000 (-21.24%) | -$558,763,000 (18.20%) | -$683,104,000 (-44.95%) |
Tax Assets | $4,385,000 (21.30%) | $3,615,000 (168.77%) | $1,345,000 (-56.19%) | $3,070,000 (78.18%) |
Tax Liabilities | $4,889,000 (169.96%) | $1,811,000 (115.60%) | $840,000 (0%) | $0 (0%) |
Total Debt | $18,478,000 (-30.61%) | $26,630,000 (-4.86%) | $27,989,000 (-13.17%) | $32,233,000 (278.23%) |
Debt Current | $2,740,000 (-35.70%) | $4,261,000 (28.27%) | $3,322,000 (153.59%) | $1,310,000 (-51.66%) |
Debt Non-Current | $15,738,000 (-29.64%) | $22,369,000 (-9.32%) | $24,667,000 (-20.23%) | $30,923,000 (432.05%) |
Total Liabilities | $124,323,000 (7.11%) | $116,074,000 (-25.48%) | $155,769,000 (11.23%) | $140,038,000 (9.02%) |
Liabilities Current | $88,294,000 (58.34%) | $55,763,000 (-41.69%) | $95,625,000 (33.08%) | $71,853,000 (-16.12%) |
Liabilities Non-Current | $36,029,000 (-40.26%) | $60,311,000 (0.28%) | $60,144,000 (-11.79%) | $68,185,000 (59.36%) |
ZYME Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $76,304,000 (0.38%) | $76,012,000 (-81.57%) | $412,482,000 (1446.03%) | $26,680,000 (-31.50%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $61,506,000 (-12.69%) | $70,446,000 (-3.97%) | $73,358,000 (72.36%) | $42,561,000 (-22.92%) |
Research & Development Expense | $134,621,000 (-6.27%) | $143,619,000 (-31.15%) | $208,596,000 (4.43%) | $199,752,000 (16.68%) |
Operating Expenses | $213,414,000 (-0.30%) | $214,065,000 (-24.08%) | $281,954,000 (16.36%) | $242,313,000 (7.02%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $6,084,000 (1171.13%) | -$568,000 (-105.21%) | $10,893,000 (2211.05%) | -$516,000 (-220.28%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$122,695,000 (-3.39%) | -$118,674,000 (-195.44%) | $124,341,000 (158.69%) | -$211,843,000 (-17.33%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$122,695,000 (-3.39%) | -$118,674,000 (-195.44%) | $124,341,000 (158.69%) | -$211,843,000 (-17.33%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$122,695,000 (-3.39%) | -$118,674,000 (-195.44%) | $124,341,000 (158.69%) | -$211,843,000 (-17.33%) |
Weighted Average Shares | $75,846,681 (10.14%) | $68,863,010 (5.63%) | $65,194,775 (26.46%) | $51,553,869 (2.32%) |
Weighted Average Shares Diluted | $75,878,738 (10.19%) | $68,863,010 (5.54%) | $65,249,184 (25.16%) | $52,131,596 (3.47%) |
Earning Before Interest & Taxes (EBIT) | -$116,611,000 (2.21%) | -$119,242,000 (-188.17%) | $135,234,000 (163.68%) | -$212,359,000 (-17.90%) |
Gross Profit | $76,304,000 (0.38%) | $76,012,000 (-81.57%) | $412,482,000 (1446.03%) | $26,680,000 (-31.50%) |
Operating Income | -$137,110,000 (0.68%) | -$138,053,000 (-205.77%) | $130,528,000 (160.53%) | -$215,633,000 (-15.02%) |
ZYME Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $38,756,000 (118.70%) | -$207,253,000 (-284.88%) | -$53,849,000 (-137.24%) | $144,596,000 (432.86%) |
Net Cash Flow from Financing | -$20,452,000 (-124.99%) | $81,847,000 (-24.62%) | $108,582,000 (1255.41%) | $8,011,000 (-97.41%) |
Net Cash Flow from Operations | -$110,044,000 (6.98%) | -$118,303,000 (-182.09%) | $144,109,000 (174.88%) | -$192,451,000 (-27.11%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$91,454,000 (62.42%) | -$243,355,000 (-222.26%) | $199,045,000 (595.52%) | -$40,169,000 (-135.36%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $41,822,000 (120.58%) | -$203,176,000 (-398.91%) | -$40,724,000 (-125.79%) | $157,881,000 (524.70%) |
Capital Expenditure | -$1,991,000 (19.52%) | -$2,474,000 (69.64%) | -$8,150,000 (34.30%) | -$12,404,000 (-187.80%) |
Issuance (Repayment) of Debt Securities | -$14,000 (33.33%) | -$21,000 (-50.00%) | -$14,000 (17.65%) | -$17,000 (58.54%) |
Issuance (Purchase) of Equity Shares | -$20,264,000 (-124.74%) | $81,921,000 (-24.98%) | $109,192,000 (1184.91%) | $8,498,000 (-97.25%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $286,000 (-19.21%) | $354,000 (74.38%) | $203,000 (162.46%) | -$325,000 (40.91%) |
Share Based Compensation | $17,792,000 (119.60%) | $8,102,000 (101.79%) | $4,015,000 (-62.67%) | $10,756,000 (-63.06%) |
Depreciation Amortization & Accretion | $11,193,000 (-35.32%) | $17,305,000 (44.16%) | $12,004,000 (25.26%) | $9,583,000 (-6.77%) |
ZYME Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -160.80% (-3.01%) | -156.10% (-618.60%) | 30.10% (103.79%) | -794.00% (-71.31%) |
EBITDA Margin | -138.20% (-3.06%) | -134.10% (-475.63%) | 35.70% (104.70%) | -760.00% (-74.31%) |
Return on Average Equity (ROAE) | -31.70% (-20.99%) | -26.20% (-162.09%) | 42.20% (161.07%) | -69.10% (-77.63%) |
Return on Average Assets (ROAA) | -24.30% (-19.70%) | -20.30% (-171.23%) | 28.50% (159.62%) | -47.80% (-55.70%) |
Return on Sales (ROS) | -152.80% (2.61%) | -156.90% (-578.35%) | 32.80% (104.12%) | -795.90% (-72.12%) |
Return on Invested Capital (ROIC) | -34.00% (-7.26%) | -31.70% (-129.79%) | 106.40% (165.00%) | -163.70% (-147.66%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -9.04 (-49.59%) | -6.04 (-246.80%) | 4.12 (203.18%) | -3.99 (69.79%) |
Price to Sales Ratio (P/S) | 14.55 (54.59%) | 9.41 (657.89%) | 1.24 (-96.08%) | 31.67 (-48.19%) |
Price to Book Ratio (P/B) | 2.98 (90.22%) | 1.56 (55.88%) | 1 (-67.22%) | 3.06 (-42.03%) |
Debt to Equity Ratio (D/E) | 0.37 (46.80%) | 0.25 (-20.89%) | 0.32 (-43.77%) | 0.56 (79.55%) |
Earnings Per Share (EPS) | -1.62 (5.81%) | -1.72 (-190.05%) | 1.91 (146.47%) | -4.11 (-14.80%) |
Sales Per Share (SPS) | 1.01 (-8.88%) | 1.1 (-82.55%) | 6.33 (1121.43%) | 0.52 (-32.99%) |
Free Cash Flow Per Share (FCFPS) | -1.48 (15.79%) | -1.75 (-184.12%) | 2.08 (152.47%) | -3.97 (-28.57%) |
Book Value Per Share (BVPS) | 4.47 (-33.84%) | 6.75 (-10.73%) | 7.56 (56.48%) | 4.83 (-40.61%) |
Tangible Assets Book Value Per Share (TABVPS) | 5.89 (-27.77%) | 8.15 (-15.39%) | 9.63 (33.02%) | 7.24 (-29.98%) |
Enterprise Value Over EBIT (EV/EBIT) | -8 (-33.33%) | -6 (-300.00%) | 3 (200.00%) | -3 (72.73%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -8.6 (-32.94%) | -6.47 (-321.93%) | 2.91 (209.51%) | -2.66 (76.58%) |
Asset Turnover | 0.15 (16.15%) | 0.13 (-86.23%) | 0.94 (1473.33%) | 0.06 (-9.09%) |
Current Ratio | 3.4 (-54.04%) | 7.41 (30.00%) | 5.7 (42.01%) | 4.01 (-24.49%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$112,035,000 (7.24%) | -$120,777,000 (-188.83%) | $135,959,000 (166.37%) | -$204,855,000 (-31.56%) |
Enterprise Value (EV) | $906,227,981 (37.47%) | $659,237,645 (53.67%) | $429,008,028 (-20.50%) | $539,645,470 (-72.03%) |
Earnings Before Tax (EBT) | -$116,611,000 (2.21%) | -$119,242,000 (-188.17%) | $135,234,000 (163.68%) | -$212,359,000 (-17.90%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$105,418,000 (-3.41%) | -$101,937,000 (-169.23%) | $147,238,000 (172.61%) | -$202,776,000 (-19.39%) |
Invested Capital | $310,580,000 (-17.07%) | $374,518,000 (134.95%) | $159,406,000 (20.95%) | $131,791,000 (-34.72%) |
Working Capital | $212,157,000 (-40.60%) | $357,163,000 (-20.47%) | $449,081,000 (107.56%) | $216,367,000 (-41.43%) |
Tangible Asset Value | $446,499,000 (-20.44%) | $561,208,000 (-10.63%) | $627,954,000 (68.23%) | $373,278,000 (-28.36%) |
Market Capitalization | $1,008,366,981 (38.64%) | $727,320,645 (46.89%) | $495,151,028 (-35.11%) | $763,019,470 (-64.77%) |
Average Equity | $387,476,500 (-14.45%) | $452,901,750 (53.86%) | $294,360,000 (-4.01%) | $306,660,000 (-33.91%) |
Average Assets | $504,907,250 (-13.69%) | $585,010,750 (33.87%) | $436,983,250 (-1.33%) | $442,876,250 (-24.73%) |
Invested Capital Average | $342,965,500 (-8.73%) | $375,758,000 (195.60%) | $127,118,000 (-2.01%) | $129,719,250 (-52.43%) |
Shares | 68,877,526 (-1.61%) | 70,001,987 (11.12%) | 62,996,314 (35.32%) | 46,553,964 (1.58%) |